Member Info for aj242

Filter, I have been bored for 2 years now, except when the Times article came out lol

all very quiet here, optimism has faded away. Still hoping to hear from the Welsh Government later this month...

bloody hell, they really have come out of the woodworks today haven't they lol

People really need to take a step back with the despair here. The PII results clearly indicate that PIII will be massively signficant. PII was NEVER going to be a ticket to MA. Be patient ffs

Personally don’t think we will be announced as the sovereign test this week. Looking at omegas tweets, they seem to be under the impression it will be announced after the local elections so I’m thinking CE mark this week and government contract next week

Great point Tornado- completely went over my head! Huge cost saving for the NHS right there

*facepalm"- scinv, you're digging yourself a hole here. Please stop trying to act smart about things you honestly don't have the faintest idea about. I am not going down a tit for tat alley with this one, thats the last I will say on this. For those that understand how it works, understands what I am talking about.

As a final signatory, trust me when I say I know what I am talking about lol

and please bare in mind that a lot of what is in the abpi is also bound by UK law. I do not know of a single UK pharma company that is either not a member nor has formally accepted the code. Anyway, going down a tangent now.

Yes Andy- we all believe that a pharma director spends his days on LSE.

scinv- last year we had a statistically signficant and clinically signifcant study, hence, a lot of what was said could be perfectly substantiated by the data.

Look at the numbers the testing companies are getting for their antigen and antibody tests, taking them similar times to recruit very few patients. Its an issue all round.
Atea have an antiviral they are developing with Roche. PII was expected a while back, but radio silence.
Recruitment is providing to be far more difficult than people anticipated across the board.

andyrp- granted SNG is not a member, but you have shown that you have a very limited knowledge of pharma with that comment. Being an ABPI member is what every single pharma company aspires do in this country. Whether you are a member or not, acting in such accord is something all pharma companies in the UK strive to do and rightfully so. This isn't America.

Docdaneeka- you hit the nail on the head with both your posts there and especially "our initial reponse was overwhelmingly positive and that was the correct response". Sub par presenting skills seems to have spooked most people here. Add on the dips and just be patient over the next 4-6 months

disagree- this has shown which patients it works best in. It still works in the home setting, the trial needs to be adapted to look at patients who are very breathless rather than ITT.

earlier setting= lots more patients=lots more sales but always a harder market to crack

Maybe you are referring to Advanced Budgetary Notifications? Again, not something which they can discuss in a presentation setting, only with appropriate people in the NHS who are buyers.
Nonetheless, we are on the same page here.

Totally agree white rabbit. For me, these prices just allows me to buy a few more shares. I don't hold anywehere near as many shares as I would like to be honest.

Torna- what do you mean by " prescription specification"? I agree with your last two sentences most definitely

fair enough nitro.

The deramping comments do amuse me from others however. They seem to have bought in on the 200p highs are now venting their frustrations. Again, similar to those that bought at 75p and saw the SP dip to 40p. Fact is, covid isn't going, probably not in our lifetime, it will always need treating and especially over the next 2-3 years. The phase 2 had no issues at all, no uncertainties, the phase 3 has just been de-risked by todays information with us now knowing that the population chosen is THE best population for the drug to work.

But it seems like most people on aim only care about presentation delivery...